| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 08/07/1996 | CN1128536A Benzopyrans and pharmaceutical compositions containing them |
| 08/06/1996 | US5543533 Photochromic products and method for their preparation |
| 08/06/1996 | US5543427 Carbamoyloxylabdanes |
| 08/06/1996 | US5543298 Method for assaying the sod activity by using a self-oxidizable compound necessary for its implementation, self-oxidizable compounds and preparation thereof |
| 08/01/1996 | WO1996022985A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders |
| 08/01/1996 | WO1996022791A1 Novel synergistic compositions useful as anti-tumor or anti-retroviral agents |
| 08/01/1996 | WO1996016052A3 Certain substituted 1-aryl-3-piperazin-1'-yl propanones |
| 08/01/1996 | WO1996006604A3 Methods for identifying and treating resistant tumors |
| 08/01/1996 | CA2208075A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders |
| 07/31/1996 | EP0723536A1 An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 07/31/1996 | EP0723441A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 07/30/1996 | US5541180 Headache therapy |
| 07/25/1996 | WO1996022325A1 Stabiliser mixture made from chromane derivatives and inert organic solvents, and microcapsules containing the said stabiliser mixture |
| 07/25/1996 | WO1996022288A1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/25/1996 | WO1996022093A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis |
| 07/25/1996 | WO1996022092A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity |
| 07/25/1996 | WO1996022091A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders |
| 07/25/1996 | WO1996022077A1 Aryl ketones for colouring keratin-containing fibres |
| 07/25/1996 | DE19501303A1 Arylketone zum Färben keratinhaltiger Fasern Arylketones for dyeing keratin fibers |
| 07/25/1996 | CA2210682A1 Glycoprotein iib/iiia antagonists |
| 07/25/1996 | CA2208856A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders |
| 07/25/1996 | CA2208852A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis |
| 07/25/1996 | CA2208837A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity |
| 07/24/1996 | EP0723156A2 Assay normalization method |
| 07/23/1996 | US5539128 Compounds for inhibiting leukotriene receptors as antiasmatics, antiarthritics, skin disorders, antiulcer agents or cardiovascular disorders |
| 07/23/1996 | US5539112 Anticarcinogenic or antitumor agents |
| 07/23/1996 | US5538993 Certain tetrahydrocannabinol-7-oic acid derivatives |
| 07/18/1996 | WO1996021444A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of gynaecological disorders |
| 07/18/1996 | WO1996021443A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment |
| 07/18/1996 | WO1996021442A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia |
| 07/18/1996 | WO1996021440A1 Methods for increasing the bioavailability of biological active agents |
| 07/18/1996 | DE19501053A1 Stabilisatorgemisch aus Chromanderivaten und inerten organischen Lösungsmitteln sowie dieses Stabilisatorgemisch enthaltende Mikrokapseln Stabilizer mixture containing from chroman and inert organic solvents, and this stabilizer mixture microcapsules |
| 07/18/1996 | CA2208868A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia |
| 07/18/1996 | CA2208861A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of gynaecological disorders |
| 07/18/1996 | CA2208859A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment |
| 07/17/1996 | EP0625209B1 Method for assaying the sod activity by using a self- oxidizable compound necessary for its implementation, self- oxidizable compounds and preparation thereof |
| 07/17/1996 | CN1126721A Process for preparing hydroxyflavan compounds |
| 07/16/1996 | US5536852 Etherification, cyclization |
| 07/16/1996 | US5536833 Process for the preparation of intermediates useful in the preparation of pyranyl cyanoguanidine derivatives |
| 07/16/1996 | US5536733 Gastrointestinal |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | WO1996020913A1 Novel trienoic retinoid compounds and methods |
| 07/11/1996 | CA2209134A1 Tricyclic retinoids, methods for their production and use |
| 07/10/1996 | EP0720551A1 Hydraulic system for anti-lock braking installations in motor vehicles |
| 07/09/1996 | US5534536 Inhibitors of thromboxane a2 synthetase, 5-lipoxygenase; scavengers of active oxygen species |
| 07/09/1996 | US5534533 Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |
| 07/09/1996 | US5534529 Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 07/04/1996 | WO1996020187A2 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 07/04/1996 | WO1996020186A1 Carboxylic acid derivatives, process for producing the same, and medicinal composition containing the same |
| 07/04/1996 | WO1996020152A1 Salts of aromatic hydroxyl compounds and their use as brighteners |
| 07/04/1996 | WO1996019987A1 Use of nebivolol as an anti-atherogenic |
| 07/04/1996 | CA2208723A1 Salts of aromatic hydroxyl compounds and their use as brighteners |
| 07/03/1996 | EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 07/03/1996 | EP0719554A1 Chondroprotective flavonoids |
| 07/03/1996 | CN1125938A Bicyclic amide derivatives and their use as muscle relaxants |
| 07/03/1996 | CN1032204C Process for preparing acetylenes disubstituted with phenyl group and heterobicyclic group having retinoid like activity |
| 07/02/1996 | US5532387 Cyclization of trimethylhydroquinone and an alkenyl alcohol, reusable catalyst, iiib fluorosulfonate, nitrate, sulfate, or fluoroalkylsulfonate |
| 07/02/1996 | US5532383 Leukotriene B4 antagonists |
| 07/02/1996 | US5532361 Spiro-pyranic compounds endowed with photochromic characteristics |
| 07/02/1996 | US5532266 Treatment of hypoxia, antiedemic agents or antiinflammatory agents |
| 07/02/1996 | US5532146 Method for rendering ligase-based amplification products unamplifiable |
| 07/02/1996 | US5532145 Purification of polymerase |
| 07/02/1996 | US5532012 Process for preparation of purified tea components using preconcentration by cream separation and solubilization followed by medium pressure chromatography and/or preparative HPLC |
| 06/29/1996 | CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 06/27/1996 | WO1996019458A2 Steroid receptor modulator compounds and methods |
| 06/27/1996 | WO1996019437A1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| 06/27/1996 | DE4446329A1 Salze aromatischer Hydroxylverbindungen und deren Verwendung als Glanzbildner Salts of aromatic hydroxy compounds and their use as brighteners |
| 06/27/1996 | CA2208347A1 Steroid receptor modulator compounds and methods |
| 06/26/1996 | EP0717739A1 Bicyclic aromatic compounds as therapeutic agents |
| 06/26/1996 | EP0607274B1 3-(N-ISOPROPYL-N-n-PROPYLAMINO)-5-(N-ISOPROPYL)CARBAMOYLCHROMAN |
| 06/26/1996 | CN1125218A Novel aryl ester compound, its production process, epoxy resin composition using said compound, and copper-clad laminate using the epoxy resin composition |
| 06/25/1996 | US5530028 Controls insects of the order lepidoptera |
| 06/25/1996 | US5530021 Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient |
| 06/25/1996 | CA1338416C Muscarinic receptor antagonists |
| 06/21/1996 | CA2164167A1 Assay normalization method |
| 06/20/1996 | WO1996018650A1 Novel receptor |
| 06/20/1996 | WO1996018609A1 Formation and utility of sulfonic acid protecting groups |
| 06/20/1996 | WO1996018382A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
| 06/20/1996 | WO1996018381A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| 06/20/1996 | WO1996018380A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations |
| 06/20/1996 | WO1996018379A1 Cosmetic and dermatological preparations with flavonoids |
| 06/20/1996 | WO1996004241A3 Benzoylguanidine derivatives as medicaments |
| 06/20/1996 | CA2207921A1 Novel receptor |
| 06/19/1996 | EP0716847A1 Cosmetic or dermatologic compositions containing cinnamic acid derivatives and a flavonoid |
| 06/19/1996 | EP0716746A1 Fluorescent oxygen channeling immunoassays |
| 06/19/1996 | CN1124922A Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 06/18/1996 | USRE35279 Aldose reductase inhibitors |
| 06/18/1996 | US5527945 Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom |
| 06/13/1996 | WO1996011021A3 Treatment of tissues to reduce subsequent response to injury |
| 06/11/1996 | US5525625 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders |
| 06/06/1996 | WO1996016957A1 3,4-dihydro-2,5,7,8-tetramethyl-benzopyran-6-ol derivatives for use as drugs |
| 06/06/1996 | WO1996016956A1 Flavanonol derivatives and hair nourishment and growth stimulant composition containing the same |
| 06/06/1996 | WO1996016955A1 Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 06/06/1996 | WO1996016632A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof |
| 06/06/1996 | CA2180745A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof |
| 06/05/1996 | EP0714396A1 Vasocontrictive dihydrobenzopyran derivatives |
| 06/05/1996 | EP0714296A1 Flavonoid and biflavonoid derivatives, their pharmaceutical compositions, their anxiolytic activity |
| 06/05/1996 | EP0610385B1 Low thermal expansion coefficient polyimides with improved elongation |
| 06/05/1996 | EP0460169B1 New chroman and thiochroman derivatives |
| 06/04/1996 | US5523420 Preparation of alpha-tocopherol and alpha-tocopheryl acetate in liquid or supercritical carbon dioxide |